$CTMX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CytomX Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CytomX Therapeutics, Inc.. Get notifications about new insider transactions in CytomX Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Option Exercise | M | 0.95 | 16,612 | 15,698 | 0 | |
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Option Exercise | M | 1.13 | 31,767 | 36,021 | 0 | |
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | M | 1.57 | 17,139 | 26,992 | 240,915 | 223.8 K to 240.9 K (+7.66 %) |
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | M | 1.45 | 27,606 | 39,998 | 223,776 | 196.2 K to 223.8 K (+14.07 %) |
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | M | 0.95 | 16,612 | 15,698 | 196,170 | 179.6 K to 196.2 K (+9.25 %) |
Aug 11 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | M | 1.13 | 31,767 | 36,021 | 179,558 | 147.8 K to 179.6 K (+21.49 %) |
Jun 21 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Buy | J | 0.00 | 17,111 | 0 | 22,111 | 5 K to 22.1 K (+342.22 %) | |
Jun 21 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Buy | J | 0.00 | 331,643 | 0 | 331,643 | 0 to 331.6 K | |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | ||
Jun 14 2016 | CTMX | CytomX Therapeutic ... | Huh Hoyoung | Director | Option Exercise | A | 10.17 | 28,000 | 284,760 | 28,000 | |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | SCARLETT JOHN A | Option Exercise | A | 10.17 | 28,000 | 284,760 | 28,000 | ||
Jun 14 2016 | CTMX | CytomX Therapeutic ... | Exter Neil | Director | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.01 | 2,700 | 27,027 | 4,244,381 | 4.2 M to 4.2 M (-0.06 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.06 | 22,842 | 229,791 | 4,247,081 | 4.3 M to 4.2 M (-0.53 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.08 | 22,885 | 230,681 | 4,269,923 | 4.3 M to 4.3 M (-0.53 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.01 | 2,700 | 27,027 | 4,244,381 | 4.2 M to 4.2 M (-0.06 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.06 | 22,842 | 229,791 | 4,247,081 | 4.3 M to 4.2 M (-0.53 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.08 | 22,885 | 230,681 | 4,269,923 | 4.3 M to 4.3 M (-0.53 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.03 | 9,731 | 97,602 | 4,292,808 | 4.3 M to 4.3 M (-0.23 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.01 | 101,767 | 1,018,688 | 4,302,539 | 4.4 M to 4.3 M (-2.31 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.03 | 9,731 | 97,602 | 4,292,808 | 4.3 M to 4.3 M (-0.23 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.01 | 101,767 | 1,018,688 | 4,302,539 | 4.4 M to 4.3 M (-2.31 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.83 | 18,428 | 199,575 | 4,404,306 | 4.4 M to 4.4 M (-0.42 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.79 | 41,193 | 444,472 | 4,422,734 | 4.5 M to 4.4 M (-0.92 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.83 | 18,428 | 199,575 | 4,404,306 | 4.4 M to 4.4 M (-0.42 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.79 | 41,193 | 444,472 | 4,422,734 | 4.5 M to 4.4 M (-0.92 %) |
Jun 02 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.75 | 22,463 | 241,477 | 4,463,927 | 4.5 M to 4.5 M (-0.50 %) |
Jun 02 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.75 | 22,463 | 241,477 | 4,463,927 | 4.5 M to 4.5 M (-0.50 %) |
Jun 01 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.60 | 25,082 | 265,869 | 4,486,390 | 4.5 M to 4.5 M (-0.56 %) |
Jun 01 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.60 | 25,082 | 265,869 | 4,486,390 | 4.5 M to 4.5 M (-0.56 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.43 | 39,887 | 416,021 | 4,511,472 | 4.6 M to 4.5 M (-0.88 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.02 | 11,456 | 114,789 | 4,551,359 | 4.6 M to 4.6 M (-0.25 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.43 | 39,887 | 416,021 | 4,511,472 | 4.6 M to 4.5 M (-0.88 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.02 | 11,456 | 114,789 | 4,551,359 | 4.6 M to 4.6 M (-0.25 %) |
May 25 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.00 | 1,200 | 12,000 | 4,562,815 | 4.6 M to 4.6 M (-0.03 %) | |
May 25 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.10 | 12,053 | 121,735 | 4,564,015 | 4.6 M to 4.6 M (-0.26 %) | |
May 25 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.00 | 1,200 | 12,000 | 4,562,815 | 4.6 M to 4.6 M (-0.03 %) |
May 25 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.10 | 12,053 | 121,735 | 4,564,015 | 4.6 M to 4.6 M (-0.26 %) |
May 23 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.09 | 6,187 | 62,427 | 4,576,068 | 4.6 M to 4.6 M (-0.14 %) | |
May 23 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.14 | 2,500 | 25,350 | 4,582,255 | 4.6 M to 4.6 M (-0.05 %) | |
May 23 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.09 | 6,187 | 62,427 | 4,576,068 | 4.6 M to 4.6 M (-0.14 %) |
May 23 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | S | 10.14 | 2,500 | 25,350 | 4,582,255 | 4.6 M to 4.6 M (-0.05 %) |
May 13 2016 | CTMX | CytomX Therapeutic ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | M | 4.47 | 2,000 | 8,946 | 245,675 | |
May 13 2016 | CTMX | CytomX Therapeutic ... | Goeltz II Robert C. | Chief Financial Off ... | Buy | M | 4.47 | 2,000 | 8,946 | 2,000 | 0 to 2 K |
Apr 26 2016 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Sell | J | 0.00 | 300,000 | 0 | 4,584,755 | 4.9 M to 4.6 M (-6.14 %) |
Jan 25 2016 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 14.46 | 80,000 | 1,156,800 | 80,000 | |
Jan 25 2016 | CTMX | CytomX Therapeutic ... | LADD CYNTHIA J | Senior VP and Gener ... | Option Exercise | A | 14.46 | 45,000 | 650,700 | 45,000 | |
Jan 25 2016 | CTMX | CytomX Therapeutic ... | Goeltz II Robert C. | Chief Financial Off ... | Option Exercise | A | 14.46 | 80,000 | 1,156,800 | 80,000 | |
Jan 25 2016 | CTMX | CytomX Therapeutic ... | HUMPHREY RACHEL | Chief Medical Offic ... | Option Exercise | A | 14.46 | 65,000 | 939,900 | 65,000 | |
Jan 25 2016 | CTMX | CytomX Therapeutic ... | McCarthy Sean A. | President and CEO | Option Exercise | A | 14.46 | 225,000 | 3,253,500 | 225,000 | |
Dec 31 2015 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | Chief Scientific Of ... | Option Exercise | M | 6.61 | 8,917 | 58,983 | 76,688 | |
Dec 31 2015 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | Chief Scientific Of ... | Buy | M | 6.61 | 8,917 | 58,983 | 13,917 | 5 K to 13.9 K (+178.34 %) |
Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 565,037 | 0 | 0 | |
Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 8,105,314 | 0 | 0 | |
Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Buy | C | 0.00 | 8,670,351 | 0 | 8,670,351 | 0 to 8.7 M |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Option Exercise | C | 0.00 | 1,318,418 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Option Exercise | C | 0.00 | 3,566,337 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Canaan IX L.P. | Director | Buy | C | 0.00 | 4,884,755 | 0 | 4,884,755 | 0 to 4.9 M |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | LADD CYNTHIA J | Senior VP and Gener ... | Option Exercise | A | 6.61 | 27,393 | 181,196 | 27,393 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | LADD CYNTHIA J | Senior VP and Gener ... | Option Exercise | A | 6.61 | 246,043 | 1,627,501 | 246,043 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | LADD CYNTHIA J | Senior VP and Gener ... | Buy | P | 12.00 | 3,000 | 36,000 | 3,000 | 0 to 3 K |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 6.61 | 85,605 | 566,251 | 85,605 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Option Exercise | A | 1.57 | 246,042 | 387,492 | 246,042 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | Kavanaugh William Michael | CSO, Head Res.&Non- ... | Buy | P | 12.00 | 5,000 | 60,000 | 5,000 | 0 to 5 K |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 1,318,418 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 3,566,337 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 1,318,418 | 0 | 1,318,418 | 0 to 1.3 M |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 3,566,337 | 0 | 3,566,337 | 0 to 3.6 M |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | P | 12.00 | 5,000 | 60,000 | 5,000 | 0 to 5 K |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | GLUCK FREDERICK W | Director | Buy | P | 12.00 | 10,000 | 120,000 | 147,791 | 137.8 K to 147.8 K (+7.26 %) |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Hadley Harbor Master Investors ... | 10% Owner | Option Exercise | C | 0.00 | 749,055 | 0 | 0 | |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Hadley Harbor Master Investors ... | 10% Owner | Buy | C | 0.00 | 749,055 | 0 | 749,055 | 0 to 749.1 K |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 160,512 | 0 | 0 | |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 160,512 | 0 | 0 | |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 114,488 | 1,373,856 | 275,000 | 160.5 K to 275 K (+71.33 %) |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Buy | P | 12.00 | 510,512 | 6,126,144 | 671,024 | 160.5 K to 671 K (+318.05 %) |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 160,512 | 0 | 160,512 | 0 to 160.5 K |
Oct 14 2015 | CTMX | CytomX Therapeutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 160,512 | 0 | 160,512 | 0 to 160.5 K |
Oct 09 2015 | CTMX | CytomX Therapeutic ... | Young Matthew P. | Director | Option Exercise | A | 12.00 | 26,985 | 323,820 | 26,985 |